Medical and laboratory products provider Cardinal Health has introduced its next-generation medical device, NTrainer System 2.0, for premature and newborn infants.
Designed for improving neonatal feeding, the NTrainer System 2.0 is claimed to be the only US Food and Drug Administration (FDA) Class II biofeedback device designed for supporting newborns and infants born prematurely develop their non-nutritive sucking (NNS) skills that are required for independent oral feeding.
The device helps reduce the neonatal intensive care unit length of stay and utilises the company’s patented technology to enhance NNS proficiency.
For reducing the time to achieve full oral feeding, the device will support proper suck-swallow-breathe coordination in premature infants.
The device leverages real-time assessment technology to provide clinicians with objective data for monitoring infant development in pre-feeding skills.
Furthermore, it provides parents with confidence regarding their infants' advancement and potential for thriving post-discharge.
Cardinal Health Medical Segment CEO Steve Mason said: “The NTrainer System demonstrates Cardinal Health's investment in innovation to help improve patient outcomes and increase caregiver confidence while providing objective data important for delivering consistent patient care.
“The NTrainer System will help some of our most vulnerable patients at the beginning of life through the first and only biofeedback device to improve NNS patterns in newborns and infants born prematurely.”
The company’s nutritional delivery portfolio consists of the Kangaroo brand, including the Kangaroo feeding tube with IRIS Technology, Kangaroo enteral feeding pumps and sets, as well as other adult, paediatric and neonatal enteral feeding products.
